Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FE548
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,114
Award facts
- Contract value 100% obligated
- $46,114.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $46,114.27 to AmerisourceBergen Drug Corp for KESIMPTA 20 mg/0.4 ml pen auto-injectors on December 30, 2025, with completion targeted for December 31, 2025. This non-competitive, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated as SPE2DX and extending through December 2026. KESIMPTA is a prescription immunosuppressant used to treat multiple sclerosis, reflecting the breadth of specialty pharmaceutical products supplied through this comprehensive contract vehicle, which supports military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, leverages this prime vendor contract to supply a diverse portfolio of medications and medical supplies including specialty drugs, generics, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitively awarded delivery orders across various therapeutic domains demonstrates its capacity to meet federal procurement requirements at scale, positioning it as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FE548?
SPE2DR26FE548 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FE548 worth?
The government has obligated $46,114 on SPE2DR26FE548.
Is contract SPE2DR26FE548 an order under another contract?
Yes. SPE2DR26FE548 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FE548 competed?
The extent of competition for SPE2DR26FE548 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award